Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Feinberg, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; RNA; SOMATOMEDIN B;

ALLELE; BECKWITH WIEDEMANN SYNDROME; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 11P; CONFERENCE PAPER; DNA METHYLATION; GENOME IMPRINTING; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; SOMATIC MUTATION;

ANIMALS; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 11; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; NEOPLASMS;

EID: 0033118754     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Feinberg, A. P. Genomic imprinting and cancer. In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 95-107. New York: McGraw-Hill, 1998.
2. Linder, D., McCaw, B., Kaiser, X., and Hecht, F. Parthenogenetic origin of benign ovarian teratomas. N. Engl. J. Med., 292: 63-66, 1975.
3. Kajii, T., and Ohama, K. Androgenetic origin of hydatidiform mole. Nature (Lond.), 268: 633, 1977.
4. Schroeder, W. T., Chao, L. Y., Dao, D. D., Strong, L. C., Pathak, S., Riccardi, V., Lewis, W. H., and Saunders, G. F. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am. J. Hum. Genet., 40: 413-420, 1987.
5. Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., and Sapienza, C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA, 86: 7480-7484, 1989.
6. Peterson, K., and Sapienza, C. Imprinting the genome: imprinted genes, imprinting genes, and a hypothesis for their interaction. Annu. Rev. Genet, 27: 7-31, 1993.
7. Ping, A. J., Reeve, A. E., Law, D. J., Young, M. R., Boehnke, M., and Feinberg, A. P. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Hum. Genet., 44: 720-723, 1989.
8. Hoovers, J. M. N., Kalikin, L. M., Johnson, L. A., Alders, M., Redeker, B., Law, D. J., Bliek, J., Steenman, M., Benedict, M., Wiegant, J., Lengauer, C., Taillon-Miller, P., Schlessinger, D., Edwards, M. C., Elledge, S. J., Ivens, A., Westerveld, A., Little, P., Mannens, M., and Feinberg, A. P. Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl. Acad. Sci. USA, 92: 12456-12460, 1995.
9. Mannens, M., Hoovers, J. M. N., Redeker, E., Verjaal, M., Feinberg, A. P., Little, P., Boavida, M., Coad, N., Steenman, M., Bliek, J., Niikawa, N., Tonoki, H., Nakamura, Y., de Boer, E. G., Slater, R. M., John, R., Cowell, J. K., Junien, C., Henry, I., Tommerup, N., Weksberg, R., Pueschel, S. M., Leschot, N. J., and Westerveld, A. Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann Syndrome and various human neoplasia. Eur. J. Hum. Genet., 2: 3-23, 1994.
10. Henry, I., Bonaiti-Pellie, C., Chehensse, V., Beldjord, C., Schwartz, C., Utermann, G., and Junien, C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (Lond.), 351: 609-610, 1991.
11. Feinberg, A. P. Multiple genetic abnormalities of 11p15 in Wilms' tumor. Med. Pediatr. Oncol., 27: 484-489, 1996.
12. Koi, M., Johnson, L. A., Kalikin, L. M., Little, P. F. R., Nakamura, Y., and Feinberg, A. P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from human chromosome 11. Science (Washington DC), 260; 361-364, 1993.
13. DeChiara, T. M., Robertson, E. J., and Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor-2 gene. Cell, 64: 849-859, 1991.
14. Bartolomei, M., Zemel, S., and Tilghman, S. M. Parental imprinting of the mouse H19 gene. Nature (Lond.), 351: 153-155, 1991.
15. Yee, D., Cullen, K. J., Paik, S., Perdue, J. F., Hampton, B., Schwartz, A., Lippman, M. E., and Rosen, N. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res., 48: 6691-6696, 1988.
16. Pommier, G. J., Garrouste, F. L., El Atiq, F., Roccabianca, M., Marvaldi, J. L., and Remacle-Bonnet, M. M. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line. Cancer Res., 52: 3182-3188, 1992.
17. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., and Tycko, B. Tumor-suppressor activity of H19 RNA. Nature (Lond.), 365: 764-767, 1993.
18. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. I., Grundy, P. E., and Feinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993.
19. Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat. Genet., 7: 433-439, 1994.
20. Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L., and Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat. Genet., 5: 143-150, 1993.
21. Rainier, S., Dobry, C. J., and Feinberg, A. P. Loss of imprinting in hepatoblastoma. Cancer Res., 55: 1836-1838, 1995.
22. Ekstrom, T. J., Cui, H., and Ohlsson, R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development (Camb.), 121: 309-316, 1995.
23. Randhawa, G. S., Cui, H., Barletta, J. M., Strichman-Almashanu, L., Talpaz, M., Kamarjian, H., Deisseroth, A., Champlin, R., and Feinberg, A. P. Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood, 91: 3144-3147, 1998.
24. Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., and Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med., 4: 1276-1280, 1998.
25. KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA, 93: 3026-3030, 1996.
26. KIP2 mutation in Beckwith-Wiedemann syndrome. Hum. Genet., 61: 304-309, 1997.
27. KIP2 mutations in Beckwith-Wiedemann syndrome. Hum. Genet., 100: 681-683, 1997.
28. KIP2 in Wilms' tumor. Cancer Res., 56: 5723-5727, 1996.
29. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (Lond.), 387: 151-158, 1997.
30. vLQT1 shows tissue-specific imprinting and is physically disrupted by Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet., 15: 181-185, 1997.
31. Hu, R-J., Lee, M. P., Connors, T. D., Johnson, L. A., Burn, T. C., Su, K., Landes, G. M., and Feinberg, A. P. A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics, 46: 9-17, 1997.
32. Lee, M. P., and Feinberg, A. P. Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res., 58: 1052-1056, 1998.
33. KIP2 gene, is biallelically expressed in fetal and adult tissues. Hum. Mol. Genet., 5: 1743-1748, 1996.
34. Lee, M. P., Reeves, C., Schmitt, A., Su, K., Connors, T. D., Hu, R-J., Brandenburg, S., Lee, M. J., Miller, G., and Feinberg, A. P. Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res., 58: 4155-4159, 1998.
35. Alders, M., Hodges, M., Hadjantonakis, A. K., Postmus, J., van Wijk, I., Bliek, J., de Meulemeester, M., Westerveld, A., Guillemot, F., Oudejans, C., Little, P., and Mannens, M. The human Achaete-Scute homologue 2 (ASCL2, HASH2) maps to chromosome 11p15.5, close to IGF2 and is expressed in extravillus trophoblasts. Hum. Mol. Genet., 6: 859-867, 1997.
36. Christofori, G., Naik, P., and Hanahan, D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during B-cell tumorigenesis. Nat. Genet., 10: 196-201, 1995.
37. Feinberg, A. P., and Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (Lond.), 301: 89-92, 1983.
38. Li, E., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
39. Barletta, J. M., Rainier, S., and Feinberg, A. P. Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res., 57: 48-50, 1997.
40. Feinberg, A. P. Genomic imprinting as a developmental process disturbed in cancer. In: W. Reik and A. Surani (eds.), pp. 165-176. Genomic Imprinting: Frontiers in Molecular Biology. Oxford: IRL Press at Oxford University Press, 1998.
41. vLQT1. Genomics, 53: 395-399, 1998.
42. Lee, M. P., Brandenburg, S., Landes, G. M., Adams, M., Miller, G., and Feinberg, A. P. Two novel genes in the center of the 11p15 imprinted domain escape genomic imprinting. Hum. Mol. Genet., in press, 1999.